Cardiogenesis Reports First Quarter 20... (gin in the first quarter of 2007. Gross ...)

Cardiogenesis Reports First Quarter 2008 Results

Date:5/15/2008

gin in the first quarter of 2007. Gross profit in absolute dollars decreased by $270,000, or 10%, to $2,457,000 for the current year quarter as compared with $2,727,000 for the 2007 first quarter.

Research and development costs were $216,000 in the first quarter of 2008 as compared with $212,000 in the first quarter of 2007.

Salaries and employee benefit expenditures of $1,524,000 in the quarter ended March 31, 2008 increased $200,000, or 15%, when compared to $1,324,000 for the quarter ended March 31, 2007.

Sales, general and administrative expenditures for the quarter ended March 31, 2008 totaled $754,000 as compared to $726,000 during the quarter ended March 31, 2007. This represents an increase of $28,000, or 4%.

As the Company noted in its recent filings, due to disruptions of, and the resulting reduced liquidity in certain financial markets, the Company's AAA rated auction rate securities with a total purchased cost of approximately $350,000 experienced failed auctions during 2008. The securities in question do not have stated maturity dates since they are perpetual securities and reset every 7 to 28 days. Due to the failed auctions, the Company was unable to sell the securities at their respective costs, resulting in a temporary decrease in fair value. As a result, the Company has classified $350,000 of auction rate securities as long-term investments in marketable securities. The Company has concluded that any unrealized losses on these investments are temporary because the Company believes that the decline in market value that has occurred is due to general market conditions, the auction rate securities continue to be of a high credit quality and interest is paid as due and the Company has the intent and ability to hold these investments to maturity or until a recovery in market value occurs. The fair value of these securities could change significantly in the future and the Company may be required to record other-than-temporary
'/>"/>

SOURCE Cardiogenesis Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
2. Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th
3. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
4. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
5. Cardiogenesis Corporation to Report 2008 First Quarter Results on May 15th
6. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
7. Haemacure Reports Third Quarter 2007 Results
8. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
9. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
10. MDS Reports Third Quarter 2007 Results
11. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006

Post Your Comments:

(Date:5/20/2013)... (PRWEB) May 20, 2013 iGearUnlimited.com asked schools' ... iPad case for students. The answers didn't surprise anyone: , ... daily use and abuse, 2. Not too bulky – need ... backpack, 3. Built-in kick-stand that works in both vertical and ... as a trackable barcodes on each case, 5. Customizable – ...

(Date:5/20/2013)... Atlanta, GA (PRWEB) May 20, 2013 ... opening of their newest office on Briarcliff Road in ... urgent care facility includes Dr. Fidias E. De ... massage therapists who will provide extensive medical services, occupational ... of the greater Atlanta metropolitan area. They also offer ...

(Date:5/20/2013)... OH (PRWEB) May 20, 2013 The ... experienced medical device law firm, report that two important ... coming months in state and federal litigations established for ... June 11th, the first C.R. Bard bellwether trial will ... Southern District of West Virginia. (In re: C.R. ...

(Date:5/19/2013)... NY (PRWEB) May 20, 2013 Alonso ... they are representing a New York woman in a ... with the National Football League (NFL). According to an ... Petitioner is seeking a declaration of paternity, order of support ... of her son with Mr. Walker. (Docket No. P-18821-13) ...

(Date:5/19/2013)... measure of the heterogeneity the variety of genetic mutations ... outcomes of patients with the most common type of head ... the journal Cancer , investigators at Massachusetts General Hospital ... measure was a better predictor of survival than most traditional ... cell carcinoma of the head and neck. , ...

Breaking Medicine News(10 mins):Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 2 Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 3 Health News:Healing Heart Urgent Care Opens New Office In Atlanta 2 Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 2 Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 3 Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 4 Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 2 Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 3 Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 2 Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 3

[0] New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments [0] Healing Heart Urgent Care Opens New Office In Atlanta [0] Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials [0] New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner [0] Genetic diversity within tumors predicts outcome in head and neck cancer

... 91% Increase in Earnings for First Half of 2008 ... Metropolitan,Health Networks, Inc. (Amex: MDF ), a ... results for the six months,and quarter ended June 30, ... that in the three months ended,June 30, 2008, the ...

... /Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group (NYSE: SCR ), a ... of the patented anti-cancer biotech,product Endu in China, today ... 2008., Highlights -- Total revenue increased ... second quarter, representing a 30.4% year-over-year growth;, ...

... Year-over-Year to $10.7 Million Backlog Reaches $72 ... Million ... to Market Recently-introduced Odyssey System Building Strong Market Momentum, ST. ... second quarter ended June,30, 2008. Revenue for the recent second quarter increased 36% ...

... goes for gold and aims to give back to Mercy Ships ... ... Laser Champion and one of Britain,s greatest medal hopes at the Beijing ... charity Mercy Ships which provides free medical care to the people of ...

... major website re-design, aimed specifically toward potential clients, with improved ... ... New York, NY (PRWEB) August 5, 2008 -- ... re-design, aimed specifically toward potential clients, with improved navigability, clear ...

... esignature, Princor representatives now benefit from a more efficient account ... ... Ontario, CA (PRWEB) August 5, 2008 -- Interlink Electronics, Inc. ... Corporation, a member of the Principal Financial Group®. The Princor® ...

Metropolitan Health Networks Reports 2008 Second Quarter Results Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results Stereotaxis Reports Record Second Quarter Revenue Olympic Sailing Hopeful Backs Hospital Ship Charity Re-Designed Legal Website Includes Blog Interlink and LaserApp Partnership Provides eSignature-Ready Forms to Princor Financial Services

(Date:5/18/2013)... 2013 The Open Paradigm Project, in ... Occupy Psychiatry , and leading organizations in the ... social media campaign showcasing video testimonials by individuals ... focuses on pathology and illness rather than wellness ... Psychiatric Association,s (APA) rollout of its latest revision ...

(Date:5/17/2013)... -- Medical devices are any medical items that are ... of their different mechanisms, actions and regulatory requirements, medical ... drug trails due to their unique clinical practices. Currently, ... both safety and efficacy (which is left to the ... as the SFDA) evaluate MDs for both safety and ...

(Date:5/17/2013)... , May 17, 2013 Orexigen® Therapeutics, Inc. (Nasdaq: ... a company overview at the UBS Global Healthcare Conference in ... for Wednesday, May 22 nd at 11 a.m. Eastern ... of the presentation, please visit the Investor Relations section of ... will be available for 14 days after the event. ...

Breaking Medicine Technology:New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2 New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3 Statistical Challenges in Medical Device Trail Evaluation 2

[0] New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses [0] Statistical Challenges in Medical Device Trail Evaluation [0] Orexigen Therapeutics to Present at the UBS Global Healthcare Conference

... ADD NEW CENTERS AND TO ... INCREASE AWARENESS AMONG CARDIOLOGISTS, PLEASANTON, Calif., April 21 ... device-based mechanical,circulatory support therapies to save, support and restore failing ... PMA (PreMarket,Approval) application, allowing the use of its HeartMate II ...

... EDISON, N.J., April 21 Nostrum, a ... today that it has,successfully completed its early, ... protein currently known as SMRX11. Nostrum,s,Symmetrix subsidiary, ... drug under Nostrum,s license from the Institute ...

Cached Medicine Technology:Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 2 Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 3 Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 4 Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation 5 Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein 2

Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein

The Easy Wrap Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is available in 5mm lea...

... system is a long term, ... clinically proven design. Available in ... correct cruciate retaining configurations. In ... of identification keeps the user ...

... The Genesis II® Total Knee System ... Now, far more is possible with less ... options, while fully addressing both clinical and ... meet these design goals, giving surgeons creative ...

Cementless hip system...

Medicine Products:

Easy Wrap Apron w/Collar: Lead Free Proven™ Posterior Stabilized Knee System Genesis II® Total Knee System Primaloc™ Cementless